Guizhou Yibai Pharmaceutical Co. Ltd. Class ASSE: 600594

"Guizhou Yibai Pharmaceutical Co., Ltd."Semi-annual Performance Forecast for 2026

Jul 15, 2026 · Issued by Guizhou Yibai Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Semi-annual Performance Forecast for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Guizhou Yibai Pharmaceutical Co. Ltd. Class A

"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List (2026 Edition)"Jul 11
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on the Cancellation of Repurchased Shares and the Change in Share CapitalJul 10
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on Election of Employee Representative DirectorJul 3
Announcement on Resolutions of the 17th Meeting of the 8th Board of DirectorsJun 17

All Guizhou Yibai Pharmaceutical Co. Ltd. Class A news releases